CDISC Japan Interchange
CDISC Japan Interchange:
Nurocor DDF: The Art of the Possible Becomes Reality.
Session 8:
Novelty in Clinical Trials and CDISC Standards: The second topic was a lecture by Mr. Barrie Nelson and Mr. Frederik Malfait from Nurocor on DDF: The Art of the Possible Becomes Reality. As stated by leadership from the Japan CDISC Coordinating Committee, “They provided a realistic image not only of the concept but also of the implementation, including actual figures on how much impact the DDF has on the actual trial timeline. Thank you very much.”
Click on an image to see full screen
Previous Post
Nurocor is looking forward to the CDISC Japan Interchange conference in Tokyo. Nurocor is presenting during Session 8 (1530-1555 Thursday, 13 June 2024) as Frederik Malfait (Senior VP, Information Architecture) presents on DDF: The Art of the Possible Becomes Reality. Attendees will learn how Nurocor has participated in the TransCelerate BioPharma Inc. DDF Program since the beginning, how we view the future of DDF, and most importantly hear about how sponsors are benefitting from a Digital Protocol Solution.
Please stop by Booth #4 to learn more and schedule a demo of the Nurocor Clinical Platform capabilities and tangible benefits.